Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8528035 | Clinical Therapeutics | 2018 | 12 Pages |
Abstract
B lymphocytes play a significant role in the pathogenesis of rheumatoid arthritis, and B cell-depletion therapy has a major effect on the course of the disease. The advances in treatment of rheumatoid arthritis include the development of targeted therapies. Anti-TNF-α therapies are widely used despite potentially serious adverse events. The data on the effects of anti-TNF-α therapies on B lymphocytes are limited and conflicting. There is a need for larger studies to better understand the effects of newly discovered therapies on the different cells of the immune system.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ozlem Pala, Alain Diaz, Bonnie B. Blomberg, Daniela Frasca,